{"title":"Trastuzumab","description":"Trastuzumab, also known by the brand name Herceptin, is a medication used to treat breast cancer that is HER2-positive. This type of breast cancer has too much of a protein called HER2, which causes the cancer cells to grow and divide uncontrollably. Trastuzumab works by targeting this protein and slowing down or stopping the growth of cancer cells. It may be used alone or in combination with other chemotherapy drugs.","products":[{"product_id":"herceptin-hylecta-trastuzumab-and-hyaluronidase-oysk-5-ml-rx","title":"Herceptin Hylecta (trastuzumab and Hyaluronidase-Oysk Injection 5 mL (RX) **Refrigeration Required","description":"\u003cp\u003eExperience effective breast cancer treatment with Herceptin Hylecta (trastuzumab and Hyaluronidase-Oysk Injection 5 mL), enhancing patient care.\u003c\/p\u003e\n\u003cp\u003eHerceptin Hylecta is a prescription medication used to treat certain types of breast cancer that are HER2-positive. It contains two active ingredients, trastuzumab and Hyaluronidase-Oysk, which work together to block the activity of HER2 proteins, slowing the growth and spread of cancer cells. The medication is administered as an injection under the skin every 3 weeks and the 5 mL refers to the amount of solution in each individual dose.\u003c\/p\u003e\n\u003cp\u003eHerceptin Hylecta is a medication for the treatment of certain types of breast cancer. It is a combination of the drug trastuzumab and the enzyme hyaluronidase. \u003cbr\u003e\u003cbr\u003eTrastuzumab is a monoclonal antibody that works by binding to a protein called HER2, which is present in large amounts in some breast cancer cells. By binding to HER2, trastuzumab can slow down or stop the growth and spread of these cancer cells.\u003cbr\u003e\u003cbr\u003eHyaluronidase is an enzyme that helps to break down a substance called hyaluronic acid, which is found in the connective tissues in the body. Hyaluronidase helps to create channels in these tissues, allowing medications like trastuzumab to be more easily absorbed into the bloodstream.\u003cbr\u003e\u003cbr\u003eTogether, trastuzumab and hyaluronidase work to fight against HER2-positive breast cancer by slowing down tumor growth and potentially shrinking it.\u003cbr\u003e\u003cbr\u003eHerceptin Hylecta is administered as an injection under the skin every 3 weeks. It may be used alone or in combination with other cancer treatments, such as chemotherapy or radiation therapy.\u003c\/p\u003e","brand":"Genentech USA","offers":[{"title":"Default Title","offer_id":40143942516808,"sku":"50242-0077-01","price":6495.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Herceptin-Hylecta-_trastuzumab-and-Hyaluronidase-Oysk-Injection-5-mL.jpg?v=1710763216"},{"product_id":"herceptin-trastuzumab-injection-150-mg-cancer-treatment-medicine-rx-refrigeration-required","title":"Herceptin Trastuzumab Injection 150 mg (RX) * Refrigeration Required *","description":"\u003cp\u003eHerceptin Trastuzumab Injection 150 mg is a type of biologic cancer treatment medicine that is used to treat certain types of breast cancer, stomach cancer, and esophageal cancer. It contains the active ingredient trastuzumab, which works by targeting and blocking a protein called HER2 on the surface of cancer cells. This protein helps these cells grow and divide, and by blocking it, Herceptin can slow or stop the growth of cancer cells.\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"color: rgb(255, 42, 0);\"\u003e\u003cem\u003e\u003cstrong\u003eThis item is Special Order.                                                                                                        -  Ships in 2-3 Business Days, Next Day Air, Signature Required.                                          -  Order cannot be cancelled once placed.\u003c\/strong\u003e\u003c\/em\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003eHerceptin Trastuzumab Injection 150 mg is a cancer treatment medicine that works by targeting and blocking the activity of a specific protein called HER2. This protein is found in high levels on the surface of some cancer cells, particularly in breast and stomach cancers.\u003cbr\u003e\u003cbr\u003eBy blocking HER2, Herceptin Trastuzumab reduces the growth and spread of cancer cells. It does this by slowing down the division of cancer cells, killing them, or stopping them from multiplying and spreading to other parts of the body.\u003cbr\u003e\u003cbr\u003eHerceptin Trastuzumab is typically used in combination with other cancer treatments, such as chemotherapy and radiation therapy. It may also be used alone for certain types of cancer.\u003cbr\u003e\u003cbr\u003eOverall, Herceptin Trastuzumab helps to slow down the progression of cancer and improve outcomes for patients with HER2-positive cancers.\u003c\/p\u003e","brand":"Genentech USA","offers":[{"title":"Default Title","offer_id":40143942647880,"sku":"50242-0132-01","price":2385.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Herceptin-Trastuzumab-Injection-150-mg-Vial.jpg?v=1710764147"},{"product_id":"ogivri-trastuzumab-injection-150-mg","title":"Ogivri Trastuzumab-Dkst Injection 150 mg **Refrigeration Required** (RX)","description":"\u003cp\u003eOgivri Trastuzumab-Dkst Injection 150 mg is a medication used in the treatment of certain types of breast cancer and stomach cancer. It contains the active ingredient trastuzumab and belongs to a class of drugs known as monoclonal antibodies. It works by specifically targeting and blocking the action of a protein called HER2, which is overexpressed in some types of cancer cells. By blocking HER2, Ogivri helps to slow down or stop the growth and spread of cancer cells.\u003c\/p\u003e\n\u003cp\u003eOgivri Trastuzumab-Dkst Injection 150 mg is a type of cancer medication called a monoclonal antibody. It targets a protein called human epidermal growth factor receptor 2 (HER2) which is found on the surface of some cancer cells. By binding to HER2, Ogivri helps to slow down or stop the growth and spread of HER2-positive cancer cells.\u003cbr\u003e\u003cbr\u003eSpecifically, Ogivri works by blocking the action of HER2, which is involved in stimulating cell growth and division. This helps to slow down the growth of cancer cells and can potentially lead to their death. In addition, Ogivri also stimulates an immune response against the cancer cells, further aiding in their destruction.\u003cbr\u003e\u003cbr\u003eOverall, by targeting HER2 and stimulating the immune system, Ogivri can help to treat certain types of breast and stomach cancers that overexpress this protein.\u003c\/p\u003e","brand":"Biocon Biologics","offers":[{"title":"Default Title","offer_id":40143946973256,"sku":"83257-0001-11","price":1295.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Ogivri-Trastuzumab-Dkst-Injection-150-mg-Vial.jpg?v=1710765239"},{"product_id":"ontruzant-trastuzumab-dttb-injection-150-mg-cancer-medicine-refrigeration-required-rxrx","title":"Ontruzant Trastuzumab-Dttb Injection 150 mg Cancer Medicine **Refrigeration Required** (RX)","description":"\u003cp\u003eOntruzant Trastuzumab-Dttb Injection 150 mg is a cancer medication used to treat certain types of breast, stomach, and gastroesophageal junction cancers that overexpress the HER2 protein. This injection contains the active ingredient trastuzumab-dttb and belongs to a class of drugs known as monoclonal antibodies. It works by binding to the HER2 protein on cancer cells and blocking their growth and division, ultimately leading to cell death. Ontruzant is biosimilar to the brand-name medication Herceptin, meaning it has been shown to be highly similar in effectiveness and safety profile. It is administered intravenously (into a vein) by a healthcare provider.\u003c\/p\u003e\n\u003cp\u003eOntruzant Trastuzumab-Dttb belongs to a class of medications known as monoclonal antibodies. It works by binding to a specific protein called HER2 (human epidermal growth factor receptor 2). HER2 is found in high levels on the surface of some cancer cells, including breast and gastric cancers. This protein helps cancer cells grow and spread.\u003cbr\u003e\u003cbr\u003eBy blocking the function of HER2, Ontruzant Trastuzumab-Dttb slows down the growth and spread of cancer cells. It also stimulates the body's immune system to attack and destroy the cancer cells.\u003cbr\u003e\u003cbr\u003eIn addition, Ontruzant Trastuzumab-Dttb may work with other chemotherapy medications to further inhibit the growth of cancer cells.\u003cbr\u003e\u003cbr\u003eOverall, Ontruzant Trastuzumab-Dttb helps in treating cancers that overexpress HER2 protein, such as breast and gastric cancers.\u003c\/p\u003e","brand":"Organon Biosimilar","offers":[{"title":"Default Title","offer_id":40143947202632,"sku":"78206-0147-01","price":1795.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Ontruzant--78206-0147-01-Trastuzumab-Dttb-Injection.jpg?v=1710767106"},{"product_id":"ontruzant-trastuzumab-dttb-injection-420-mg-cancer-medicine-refrigeration-required-rx","title":"Ontruzant Trastuzumab-Dttb Injection 420 mg **Refrigeration Required** (RX)","description":"\u003cp\u003eOntruzant Trastuzumab-Dttb Injection 420 mg is a cancer medicine used to treat breast cancer, stomach cancer, and other types of cancer that overexpress the HER2 protein. It belongs to a class of drugs called monoclonal antibodies, which work by targeting and inhibiting the activity of HER2 receptors on cancer cells. By blocking these receptors, Ontruzant helps to slow or stop the growth and spread of cancer cells in the body. This medication is administered through injection by a healthcare professional.\u003c\/p\u003e\n\u003cp\u003eOntruzant Trastuzumab-Dttb is a monoclonal antibody that works by binding to a protein called HER2, which is found on the surface of some cancer cells. When this antibody binds to HER2, it blocks the growth and spread of cancer cells. This helps to slow down or stop the growth of cancer and can also help the body's immune system to recognize and attack cancer cells. It is commonly used to treat breast cancer that overexpresses the HER2 protein.\u003c\/p\u003e\n\u003cp\u003eBrand: Organon Biosimilar\u003cbr\u003eStrength: 420 mg\u003cbr\u003eNDC: 78206-0148-01\u003cbr\u003eType: Powder Vial\u003c\/p\u003e","brand":"Organon Biosimilar","offers":[{"title":"Default Title","offer_id":40143947464776,"sku":"78206-0148-01","price":5150.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Ontruzant-Trastuzumab-Dttb-Injection-420-mg-Cancer-Medicine.jpg?v=1710767571"}],"url":"https:\/\/www.mountainside-medical.com\/collections\/trastuzumab\/biocon-biologics+breast-cancer-medication.oembed","provider":"Mountainside Medical","version":"1.0","type":"link"}